EXCLUSIVE: Adial Pharmaceuticals' Potential Treatment For Alcohol Use Disorder Shows Encouraging Safety, Patient Compliance - Adial Pharmaceuticals (NASDAQ:ADIL)

Adial Pharmaceuticals releases a peer-reviewed article on AD04, its lead investigational drug for Alcohol Use Disorder. The study highlights a strong safety profile & liver safety compared to a placebo.

Related Keywords

, Adial Pharmaceuticals Inc , Adial Pharmaceuticals , Alcohol Use Disorder ,